BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Lorus Therapeutics Inc. 

2 Meridian Road

Toronto  Ontario  M9W 4Z7  Canada
Phone: 416-798-1200 Fax: 416-798-2200


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Lorus Therapeutics Inc. (LRP) Implements Name Change To Aptose Biosciences 9/2/2014 10:57:39 AM
Lorus Therapeutics Inc. (LRP) Announces Results Of Annual And Special Meeting Of Shareholders 8/20/2014 7:48:18 AM
Lorus Therapeutics Inc. (LRP) To Present At The Canaccord Genuity 34th Annual Growth Conference 8/7/2014 10:26:35 AM
Lorus Therapeutics Inc. (LRP) Receives FDA Clearance Of IND To Initiate LOR-253 Clinical Program In Patients With AML, MDS And Other Blood Cancers 7/28/2014 7:33:53 AM
Lorus Therapeutics Inc. (LRP) To Host Fourth Quarter And Year End 2014 Financial Results Conference Call And Webcast 7/14/2014 10:34:05 AM
Lorus Therapeutics Inc. (LRP) Provides Update On Warrants 6/10/2014 9:55:07 AM
Lorus Therapeutics Inc. (LRP) To Present Data On Lead Compound LOR-253 At American Association for Cancer Research Annual Meeting 2014 4/4/2014 10:44:37 AM
Lorus Therapeutics Inc. (LRP)'s President And COO To Step Down 3/20/2014 8:12:12 AM
Lorus Therapeutics Inc. (LRP) Completes New Executive Management Team 12/2/2013 6:39:07 AM
Lorus Therapeutics Inc. (LRP) to Focus LOR-253 Development on AML Based on Genetic Insights into the Causes of Certain Hematologic Cancers 10/29/2013 10:54:46 AM
12345678910...